AdaptHealth Corp.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.24B | $3.26B | $3.20B | $2.94B | $2.45B | $1.06B | $529.6M | $345.3M |
| Sleep | — | — | $1.16B | $1.04B | $870.3M | — | — | — |
| Respiratory | — | — | $631.0M | $615.0M | $591.2M | — | — | — |
| Diabetes | — | — | $585.0M | $534.4M | $578.8M | — | — | — |
| HME and Other | — | — | $828.8M | $750.8M | $413.7M | — | — | — |
| Cost of Revenue | $2.64B | $2.58B | $2.58B | $2.39B | $2.01B | $898.6M | $440.7M | $293.4M |
| Gross Profit | $609.2M | $681.1M | $624.8M | $549.8M | $445.1M | $157.8M | $88.9M | $51.9M |
| Gross Margin | 18.8% | 20.9% | 19.5% | 18.7% | 18.1% | 14.9% | 16.8% | 15.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $382.3M | $359.2M | $334.6M | $324.8M | $167.5M | $89.3M | $56.5M | $18.1M |
| Operating Income | $90.9M | $263.7M | $-598.4M | $190.4M | $225.6M | $71.3M | $29.4M | $31.1M |
| Operating Margin | 2.8% | 8.1% | -18.7% | 6.5% | 9.2% | 6.8% | 5.5% | 9.0% |
| Interest Expense | $103.6M | $124.7M | $130.3M | $109.4M | $95.2M | $41.4M | $39.3M | $7.5M |
| Pretax Income | $-15.2M | $136.0M | $-723.8M | $97.9M | $191.0M | $-206.0M | $-21.9M | $22.2M |
| Income Tax Expense | $50.9M | $41.2M | $-49.0M | $24.8M | $32.8M | $-12.0M | $739.0K | $-2.1M |
| Net Income | $-70.8M | $90.4M | $-678.9M | $69.3M | $156.2M | $-161.6M | $-21.3M | $23.3M |
| Net Margin | -2.2% | 2.8% | -21.2% | 2.4% | 6.4% | -15.3% | -4.0% | 6.7% |
| EPS (Basic) | $-0.52 | $0.62 | $-5.06 | $0.47 | $1.12 | $-1.03 | $-0.16 | $0.33 |
| EPS (Diluted) | $-0.52 | $0.61 | $-5.31 | $0.33 | $0.67 | $-1.03 | $-0.16 | $0.33 |
| Shares Outstanding (Basic) | 135.1M | 133.8M | 134.2M | 134.2M | 126.3M | 157.5M | 135.3M | 43.2M |
| Shares Outstanding (Diluted) | 135.1M | 135.5M | 134.4M | 139.0M | 133.0M | 157.5M | 135.3M | 43.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |